{
    "2019-10-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "TIMELINE-Popular heartburn medicine Zantac pulled off store shelves",
                "features": {
                    "keywords": [
                        "Zantac",
                        "pulled",
                        "store",
                        "shelves"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Top Analyst Reports for Pfizer, DISH & Micron",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "DISH",
                        "Micron"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "telecommunications",
                        "semiconductors"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Novartis (NVS) Announces Data on Asthma Drugs & Kisqali",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Asthma",
                        "Drugs",
                        "Kisqali"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Why this UC Berkeley gene therapy spinout is targeting a $100 million IPO",
                "features": {
                    "keywords": [
                        "UC Berkeley",
                        "gene therapy",
                        "spinout",
                        "IPO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}